<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="t0003" orientation="portrait" position="float">
 <label>Table 3.</label>
 <caption>
  <p>The antioxidant effects of 
   <italic>Allium cepa</italic> and its constituents.
  </p>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col width="80pt"/>
   <col width="80pt"/>
   <col width="80pt"/>
   <col width="80pt"/>
   <col width="80pt"/>
  </colgroup>
  <thead>
   <tr>
    <th align="left">Preparations</th>
    <th align="center">Doses</th>
    <th align="center">Model of study</th>
    <th align="center">Effects</th>
    <th align="center">Reference</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left">Essential oil</td>
    <td align="left">100 mg/kg/day, gavage</td>
    <td align="left">Nicotine-induced damages in Sprague–Dawley rats</td>
    <td align="left">Reduced LPO,
     <break/>increased SOD, CAT and GSH
    </td>
    <td align="left">Helen et al. (
     <xref ref-type="bibr" rid="CIT0051">2000</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Onion powder</td>
    <td align="left">2 g/100 g body weigh/day, orally</td>
    <td align="left">Murine infected with 
     <italic toggle="yes">Schistosoma mansoni</italic>
    </td>
    <td align="left">Reduced LPO,
     <break/>increased SOD, TrxR, SDH, GR
    </td>
    <td align="left">Mantawy et al. (
     <xref ref-type="bibr" rid="CIT0083">2012</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Aqueous</td>
    <td align="left">1mL/day, orally</td>
    <td align="left">Doxorubicin-induced
     <break/>hepatotoxicity in Sprague-Dawley rats
    </td>
    <td align="left">Reduced MDA, increased SOD, GSH and GPx</td>
    <td align="left">Mete et al. (
     <xref ref-type="bibr" rid="CIT0087">2016</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Aqueous</td>
    <td align="left">100 and 300 mg/kg/day, orally</td>
    <td align="left">Alloxan-induced diabetic rabbits</td>
    <td align="left">Increased SOD, CAT, GPx, GSH, reduced MDA content</td>
    <td align="left">Ogunmodede et al. (
     <xref ref-type="bibr" rid="CIT0091">2011</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Aqueous</td>
    <td align="left">1 mL/day, orally</td>
    <td align="left">Cadmium-induced renal dysfunction</td>
    <td align="left">Improveed plasma and tissue levels of SOD, CAT and MDA</td>
    <td align="left">Ige et al. (
     <xref ref-type="bibr" rid="CIT0053">2009</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Aqueous</td>
    <td align="left">0.5 and 1 mL/100 g bw/day, gavage</td>
    <td align="left">Cadmium-induced
     <break/>nephrotoxicity in Wistar rats
    </td>
    <td align="left">Reduced LPO and GST, increased SOD, CAT and GSH</td>
    <td align="left">Suru (
     <xref ref-type="bibr" rid="CIT0123">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Methanolic</td>
    <td align="left">600 mg/kg/day, orally</td>
    <td align="left">Cyanide-induced renal toxicity in Wistar rats</td>
    <td align="left">Reduced LPO and MDA, increased SOD, CAT and GSH</td>
    <td align="left">Ola-Mudathir and Maduagwu (
     <xref ref-type="bibr" rid="CIT0094">2014</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Aqueous</td>
    <td align="left">0.5 and 1 mL/100 g bw/day, gavage</td>
    <td align="left">Endogenous hepatic and renal antioxidant status in Wistar rats</td>
    <td align="left">Decreased MDA, increased GSH, GST, SOD and CAT</td>
    <td align="left">Suru and Ugwu (
     <xref ref-type="bibr" rid="CIT0124">2015</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Onion juice</td>
    <td align="left">3 mL/day, gavage</td>
    <td align="left">
     <italic toggle="yes">Escherichia coli</italic> induced testis and seminiferous tubules damage in Wistar rats
    </td>
    <td align="left">Enhanced total antioxidant capacity</td>
    <td align="left">Shahverdi et al. (
     <xref ref-type="bibr" rid="CIT0112">2017</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Aqueous</td>
    <td align="left">0.5 and 1 mL/100 g bw/day, gavage</td>
    <td align="left">Cadmium-induced prostate glands damage in Wistar rats</td>
    <td align="left">Reduced GST, increased SOD, CAT and GSH</td>
    <td align="left">Suru and Ugwu (
     <xref ref-type="bibr" rid="CIT0124">2015</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Aqueous</td>
    <td align="left">0.5 and 1 mL/100 g bw/day, gavage</td>
    <td align="left">Cadmium-induced sperm and testicular damage in Wistar rats</td>
    <td align="left">Reduced LPO, GST and MDA, increased SOD, CAT and GSH</td>
    <td align="left">Ola-Mudathir et al. (
     <xref ref-type="bibr" rid="CIT0095">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Onion juice</td>
    <td align="left">0.175, 0.35, or 0.7 mg/mL in drinking water</td>
    <td align="left">Wistar rat model of asthma</td>
    <td align="left">Decreased NO2, NO3
     <sup>–</sup>, MDA, elevated SOD and CAT
    </td>
    <td align="left">Marefati et al. (
     <xref ref-type="bibr" rid="CIT0084">2018</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Aqueous</td>
    <td align="left">0.4 g/ mL/day, gavage</td>
    <td align="left">STZ-induced diabetic rats Wistar rats</td>
    <td align="left">Reduced lipid hydroperoxide and lipoperoxide</td>
    <td align="left">Campos et al. (
     <xref ref-type="bibr" rid="CIT0021">2003</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Onion juice</td>
    <td align="left">100 mL/day, orally</td>
    <td align="left">Subjects with mild hypercholesterolaemia</td>
    <td align="left">Increased total antioxidant capacity and extended time of LDL oxidation</td>
    <td align="left">Jain et al. (
     <xref ref-type="bibr" rid="CIT0055">2018</xref>), Lu et al. (
     <xref ref-type="bibr" rid="CIT0081">2015</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Onion juice</td>
    <td align="left">100 mL/day, orally</td>
    <td align="left">Health subjects</td>
    <td align="left">Improved total antioxidant capacity, GSH and GR</td>
    <td align="left">Law et al. (
     <xref ref-type="bibr" rid="CIT0073">2016</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Quercetin</td>
    <td align="left">5 mg/kg</td>
    <td align="left">Hyperuricemic Wistar rats</td>
    <td align="left">Improved oxidative stress</td>
    <td align="left">Haidari et al. (
     <xref ref-type="bibr" rid="CIT0042">2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Quercetin</td>
    <td align="left">1–10 μM</td>
    <td align="left">Cortical neuronal cells</td>
    <td align="left">Protected cells from oxidative stress by inactivation of protein kinase C-ε</td>
    <td align="left">Lee and Jung (
     <xref ref-type="bibr" rid="CIT0074">2016</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Quercetin</td>
    <td align="left">100 mg/kg, orally</td>
    <td align="left">Paracetamol induced oxidative stress in Wistar rats</td>
    <td align="left">Inhibited free radicals</td>
    <td align="left">Mehta et al. (
     <xref ref-type="bibr" rid="CIT0085">2012</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Quercetin oxidation metabolite (BZF)</td>
    <td align="left">0.03 nanomolar</td>
    <td align="left">Indomethacin-induced damage in human Caco2 cells</td>
    <td align="left">Protected Caco2 cells against damage by antioxidant effect</td>
    <td align="left">Fuentes et al. (
     <xref ref-type="bibr" rid="CIT0035">2020</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">MAS</td>
    <td align="left">200 mg/kg, gavage</td>
    <td align="left">Varicocele-induced Sprague-Dawley rats</td>
    <td align="left">Improved parameters of oxidative stress such as MDA, SOD and GPx</td>
    <td align="left">Karna et al. (
     <xref ref-type="bibr" rid="CIT0062">2019</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Dihydroquercetin</td>
    <td align="left">100 mg/kg, orally</td>
    <td align="left">CCl4- induced hepatitis in rat model</td>
    <td align="left">Hepatoprotective effect</td>
    <td align="left">Teselkin et al. (
     <xref ref-type="bibr" rid="CIT0126">2000</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Polysaccharides</td>
    <td align="left">0.5-2.0 mg/mL</td>
    <td align="left">In vitro study</td>
    <td align="left">ABTS radical scavenging activity, DPPH radical scavenging activity, iron (Fe2+) chelating activity, and superoxide anion radical scavenging activity</td>
    <td align="left">Ma et al. (
     <xref ref-type="bibr" rid="CIT0082">2018</xref>)
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="TF2">
   <p>STZ: streptozocin; LPO: lipid peroxidation; SOD: superoxide dismutase; CAT: catalase; GSH: glutathione; TrxR: thioredoxin reductase; SDH: sorbitol dehydrogenase; GR: glutathione reductase; MDA: malondialdehyde; GPx: glutathione peroxidase; GST: glutathione S-transferase; NO
    <sub>2</sub>, nitrogen dioxide, NO3
    <sup>–</sup>: nitrate; BZF: 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-3(2H)-benzo-furanone; Caco2: colonic adenocarcinoma cell line; MAS: MAS: monotropein, Astragalin (kaempferol 3-
    <italic>O</italic>-glucoside) and spiraeoside; ABTS: azinobis (3-ethyl-benzothiazolin-6-sulfonic acid); DPPH: diphenyl-1-picrylhydrazyl.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
